Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells. 2006

Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA.

A major goal of immunotherapy for autoimmune diseases and transplantation is induction of regulatory T cells that mediate immunologic tolerance. The mucosal immune system is unique, as tolerance is preferentially induced after exposure to antigen, and induction of regulatory T cells is a primary mechanism of oral tolerance. Parenteral administration of CD3-specific monoclonal antibody is an approved therapy for transplantation in humans and is effective in autoimmune diabetes. We found that orally administered CD3-specific antibody is biologically active in the gut and suppresses autoimmune encephalomyelitis both before induction of disease and at the height of disease. Orally administered CD3-specific antibody induces CD4+ CD25- LAP+ regulatory T cells that contain latency-associated peptide (LAP) on their surface and that function in vitro and in vivo through a TGF-beta-dependent mechanism. These findings identify a new immunologic approach that is widely applicable for the treatment of human autoimmune conditions.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D005260 Female Females
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
February 2013, Journal of autoimmunity,
Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
January 2003, Novartis Foundation symposium,
Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
December 2007, Journal of neuroimmunology,
Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
January 2007, The British journal of ophthalmology,
Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
June 2009, Lupus,
Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
November 2008, Journal of immunology (Baltimore, Md. : 1950),
Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
March 2005, Blood,
Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
March 2009, Journal of dermatological science,
Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
August 2004, Journal of autoimmunity,
Hirofumi Ochi, and Michal Abraham, and Hiroki Ishikawa, and Dan Frenkel, and Kaiyong Yang, and Alexandre S Basso, and Henry Wu, and Mei-Ling Chen, and Roopali Gandhi, and Ariel Miller, and Ruth Maron, and Howard L Weiner
February 2004, International immunology,
Copied contents to your clipboard!